Biotechnology company and drug delivery platform innovator
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning conveyed its support
for the Food & Drug Administration’s (“FDA”) February 21 statement titled
“Smoking Cessation and Related Indications: Developing Nicotine Replacement
Therapy Drug Products”. The FDA’s statement outlined the development of safe
and effective novel nicotine replacement therapies to help smokers quit
cigarettes, stating that “novel products with different characteristics or
routes of nicotine delivery have the potential to offer additional
opportunities for health-concerned smokers interested in quitting.” Lexaria
recently entered a partnership with a leading tobacco company to use
DehydraTECH(TM) technology to develop new oral nicotine products. This
technology could provide a nicotine delivery method that harmonizes with
current FDA policies while avoiding the grave health consequences related to
smoking cigarettes and preserving the consumers’ choice.
To view the full FDA statement, visit http://ibn.fm/4RIy8
To view the full press release, visit http://ibn.fm/eC8YC
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and higher effectiveness of lipophilic active molecules. Lexaria
has multiple patents pending in over 40 countries around the world and has
patents granted in the USA and in Australia for utilization of its DehydraTECH(TM)
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment